v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net loss $ (2,608,464) $ (595,752)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation related to employees and non-employees 256,006 166,667
Depreciation expense 15,213
Change in fair value of SAFE notes 241,300
Changes in operating assets and liabilities:    
Prepaids and other assets 126,547 (17,332)
Accounts payable 106,786 124,086
Accrued expenses and other liabilities (135,164)
Change in right of use and lease liability 1,101
Net cash used in operating activities (2,237,975) (81,031)
Investing activities:    
Purchase of property and equipment (1,259,652)
Net cash used in investing activities (1,259,652)
Cash flows from financing activities:    
Proceeds from sale of common stock and warrants in private placement, net of issuance costs 14,820,975
Proceeds from issuance of restricted stock awards 20
Payment of deferred financing costs (25,000)
Proceeds from issuance of SAFE notes 1,695,000
Net cash provided by financing activities 14,820,975 1,670,020
Net increase in cash and cash equivalents 11,323,348 1,588,989
Cash and cash equivalents at beginning of the period 8,121,445 134,657
Cash and cash equivalents at end of the period 19,444,793 1,723,646
Supplemental schedule of non-cash activities:    
Right of use asset acquired in exchange for lease liability $ 189,582